Global Program Clinical Head - Oncology

Novartis; City Of London; Hybrid; GBP 100,000 - 130,000; Full time

Job summary

A leading global healthcare company is seeking a Global Program Clinical Head in London to oversee clinical programs, ensuring high-quality execution for clinical development in oncology. Candidates must have strong leadership experience and a proven track record in drug development, alongside qualifications as an MD, preferably with a PhD. This hybrid position involves significant interaction with stakeholders in a dynamic environment.

Qualifications

• 5 years professional experience as MD required.
• 10 years of experience with clinical drug development in Phases I to III/IV.
• Board certified Oncologist or >5 years in Oncology development.

Responsibilities

• Lead Global Clinical Teams and represent Clinical Development.
• Develop and execute clinical strategies for trials.
• Ensure continuous evaluation of drug safety profiles.

Skills

Budget Management

Clinical Trials

Coaching

Compliance

Cross-Functional Teams

Leadership

People Management

Risk Management

Risk Monitoring

Strategy

Education

MD or equivalent

PhD

Job description

Overview

The Global Program Clinical Head (GPCH) is the global clinical leader responsible for one or more clinical programs across indications, involving one or multiple compounds. The GPCH owns the risk benefit assessment for the program(s), and as the leader of Global Clinical Team(s) (GCT) is accountable for the design, implementation, and execution of a clinical development program(s) to support decision milestones, regulatory requirements and market access. The GCPH may contribute to disease area strategy.

Job Description

This role reports into the Clinical Development Head - Oncology.

Your responsibilities will include:

• Leads the GCT, represents Clinical Development on the Global Program Team (GPT)
• May serve as the Clinical Development Representative on Biomedical Research clinical/project teams to drive transition of pre-PoC (Proof of Concept) projects to Development Decision Point (DDP)
• May support Business Development & Licensing (BD&L) activities
• Post-Development Decision Point, leads the development and execution of the clinical strategy. Develops an endorsed Integrated Development Plan (IDP) in line with the Target Product Profile (TPP) which is designed for successful global regulatory approval/market access for one or multiple treatment indications and/or multiple programs
• Leads the creation of clinical components of key documents (e.g., Clinical Trial Protocols (CTPs), Investigator's Brochures, Clinical Study Reports (CSRs), regulatory documents including maintenance of product licenses, registration dossiers, value dossiers, pharmacoeconomic dossiers) with high quality and consistency with IDP and TPP. Supports registration, market access, commercialization, and maintenance of product licenses (e.g., Core Data Sheet, Periodic Safety Update Report, clinical benefit-risk assessment for license renewals) for the compound(s)
• Together with Patient Safety, ensures continuous evaluation of drug safety profile, including safety monitoring of clinical studies and signal detection from post-marketing surveillance. Serves as a core member of the Safety Management Team (SMT)
• As the medical expert, leads interactions with external stakeholders (e.g., regulatory authorities, key opinion leaders, data monitoring committees, advisory boards, patient advocacy groups), internal stakeholders (e.g., Research, Translational Medicine, Global Medical Affairs (GMA), Marketing, Health Economics & Outcomes Research), and internal decision boards.

Minimum Requirements

• MD or equivalent (required) PhD (preferred)
• 5 years professional experience as MD and a minimum of 10 years of experience with clinical drug development in an industry environment spanning clinical activities in Phases I through III/IV and experience with leading submission dossiers (required)
• Ideally a Board certified Oncologist OR extensive (> 5 years) experience in clinical development within the Oncology Therapeutic area
• Advanced knowledge of assigned therapeutic area required, with the capability to innovate in clinical development study designs that provide relevant evidence to decision-makers, and to interpret, discuss and present clinical trial or section program level data
• Thorough knowledge of Good Clinical Practice, clinical trial design, statistics, and regulatory/clinical development process required
• Demonstrated ability to establish strong scientific partnership with key stakeholders
• Demonstrated leadership and management skills with a documented track record of delivering high quality projects/submissions/trials in a global/matrix environment (including remote) in pharmaceutical or biotech industry

This is a hybrid role based in London.

Additional Information

Read our handbook to learn about all the ways we\'ll help you thrive personally and professionally: Novartis Life Handbook

Novartis is committed to building an outstanding, inclusive work environment and diverse teams' representative of the patients and communities we serve.

Accessibility and accommodation

Novartis is committed to working with and providing reasonable accommodation to all individuals. If, because of a medical condition or disability, you need a reasonable accommodation for any part of the recruitment process, or in order to receive more detailed information about the essential functions of a position, please send an e-mail to [e-mail] and let us know the nature of your request and your contact information. Please include the job requisition number in your message.

Skills Desired

Budget Management, Clinical Trials, Coaching, Compliance, Cross-Functional Teams, Leadership, People Management, Risk Management, Risk Monitoring, Strategy